Patricia Laiz

Mrs. Patricia Laiz


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2022 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
DBDavid Barastegui
David Barastegui
Roberto SeijasRoberto Seijas
Roberto Seijas
EAEduard Alentorn-Geli
Eduard Alentorn-Geli
AFAlfred Ferré-Aniorte
Alfred Ferré-Aniorte
PLPatricia Laiz
Patricia Laiz
RCRamon Cugat
Ramon Cugat

Verified
Journal Article
Open access
PDF file
EAEduardo Anitua
Eduardo Anitua
RPRoberto Prado
Roberto Prado
JGJorge Guadilla
Jorge Guadilla
MAMohammad Alkhraisat
Mohammad Alkhraisat
PLPatricia Laiz
Patricia Laiz
RCRamon Cugat
Ramon Cugat
The treatment of chondral and osteochondral defects is challenging. These types of lesions are painful and progress to osteoarthritis over time. Tissue engineering offers tools to address this unmet medical need. The use of an autologous cartilage construct consisting of hyaline cartilage chips embedded in plasma rich in growth factors (PRGF) has been proposed as a therapeutic alternative. The purpose of this study was to dig into the potential mechanisms behind the in vitro remodelling process that might explain the clinical success of this technique and facilitate its optimisation. Chondrocyte viability and cellular behaviour over eight weeks of in vitro culture, type II collagen synthesis, the dual delivery of growth factors by hyaline cartilage and PRGF matrix, and the ultrastructure of the construct and its remodelling were characterised. The main finding of this research is that the cartilage fragments embedded in the three-dimensional PRGF scaffold contain viable chondrocytes that are able to migrate into the fibrin network, proliferate and synthesise extracellular matrix after the second week of in vitro culture. The characterization of this three-dimensional matrix is key to unravelling the molecular kinetics responsible for its efficacy.

18 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LGLuis Garcia-Bordes
Luis Garcia-Bordes
LELorenzo Escutia
Lorenzo Escutia
SVSilvia Vizcaíno
Silvia Vizcaíno
PLPatricia Laiz
Patricia Laiz
Roberto SeijasRoberto Seijas
Roberto Seijas
RCRamon Cugat
Ramon Cugat
Background/Objectives: The anticoagulant used for blood collection is a fundamental but underexplored variable in platelet-rich plasma (PRP) preparation. Ethylenediaminetetraacetic acid (EDTA) and sodium citrate act on platelets through distinct calcium chelation mechanisms with potentially different consequences for PRP quality. Our group has previously demonstrated that biological and demographic variables independently modulate platelet composition in PRP; the present study extends this analysis to the pre-analytical anticoagulant variable. No prospective paired clinical study has systematically compared the effects of EDTA and sodium citrate on platelet morphological parameters in a real clinical setting. This study aimed to characterise these differences and evaluate their implications for orthobiologic therapy. Methods: A prospective within-subject paired-sample study was conducted at Instituto Cugat – Quirónsalud Barcelona (November 2025–April 2026). Twenty-six consecutive adult patients undergoing routine blood extraction prior to orthopaedic procedures had blood drawn simultaneously into K₂-EDTA and sodium citrate (3.2%) tubes. Full haematological analysis was performed on a Sysmex XN automated analyser within 30 minutes. Primary outcomes were mean platelet volume (MPV), platelet distribution width (PDW), large platelet ratio (P-LCR), large platelet cell count (P-LCC), and plateletcrit (PCT). Statistical comparisons used the paired t-test or Wilcoxon signed-rank test; effect sizes were quantified as Cohen's d. Results: Seven of eight platelet-related parameters differed significantly between anticoagulants (all p<0.001). Compared to sodium citrate, EDTA produced systematically higher MPV (+10.1%, d=2.81), P-LCR (+25.8%, d=2.41), P-LCC (+24.3%, d=1.70), PDW (+13.5%, d=1.33), PCT (+7.3%, d=0.78), RDW-CV (+2.0%, d=0.83), and RDW-SD (+2.6%, d=0.80). MPV was higher with EDTA in all 26/26 paired samples without exception. Total platelet count did not differ significantly (p=0.135). Effect sizes for all morphological parameters were large (d≥0.78). Conclusions: EDTA induces large, reproducible, and universal platelet morphological changes consistent with calcium chelation-induced swelling, not genuine platelet hypertrophy. These artefactual changes systematically overestimate platelet size and large platelet indices by up to 26%, with direct implications for PRP quality assessment in orthobiologic medicine. Sodium citrate should remain the anticoagulant of choice for PRP preparation. Clinicians using EDTA must recognise that morphological parameters do not reflect functional platelet capacity.

14 July 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
LGLuis Garcia-Bordes
Luis Garcia-Bordes
LELorenzo Escutia
Lorenzo Escutia
SVSilvia Vizcaíno
Silvia Vizcaíno
PLPatricia Laiz
Patricia Laiz
Roberto SeijasRoberto Seijas
Roberto Seijas
RCRamon Cugat
Ramon Cugat
Background/Objectives: The anticoagulant used for blood collection is a fundamental but underexplored variable in platelet-rich plasma (PRP) preparation. Ethylenediaminetetraacetic acid (EDTA) and sodium citrate act on platelets through distinct calcium chelation mechanisms with potentially different consequences for PRP quality. Our group has previously demonstrated that biological and demographic variables independently modulate platelet composition in PRP; the present study extends this analysis to the pre-analytical anticoagulant variable. No prospective paired clinical study has systematically compared the effects of EDTA and sodium citrate on platelet morphological parameters in a real clinical setting. This study aimed to characterise these differences and evaluate their implications for orthobiologic therapy. Methods: A prospective within-subject paired-sample study was conducted at Instituto Cugat—Quirónsalud Barcelona (November 2025–April 2026). Twenty-six consecutive adult patients undergoing routine blood extraction prior to orthopaedic procedures had blood drawn simultaneously into K2-EDTA and sodium citrate (3.2%) tubes. Full haematological analysis was performed on a Sysmex XN automated analyser within 30 min. Primary outcomes were mean platelet volume (MPV), platelet distribution width (PDW), large platelet ratio (P-LCR), large platelet cell count (P-LCC), and plateletcrit (PCT). Statistical comparisons used the paired t-test or Wilcoxon signed-rank test; effect sizes were quantified as Cohen’s d. Results: Seven of eight platelet-related parameters differed significantly between anticoagulants (all p < 0.001). Compared to sodium citrate, EDTA produced systematically higher MPV (+10.1%, d = 2.81), P-LCR (+25.8%, d = 2.41), P-LCC (+24.3%, d = 1.70), PDW (+13.5%, d = 1.33), PCT (+7.3%, d = 0.78), RDW-CV (+2.0%, d = 0.83), and RDW-SD (+2.6%, d = 0.80). MPV was higher with EDTA in all 26/26 paired samples without exception. Total platelet count did not differ significantly (p = 0.135). Effect sizes for all morphological parameters were large (d ≥ 0.78). Conclusions: EDTA is associated with large, reproducible, and universal platelet morphological changes consistent with calcium chelation-induced artefact, not genuine platelet hypertrophy. These artefactual changes systematically overestimate platelet size and large platelet indices by up to 26%, with direct implications for PRP quality assessment in orthobiologic medicine. Sodium citrate should remain the anticoagulant of choice for PRP preparation. Clinicians using EDTA must recognise that morphological parameters do not reflect functional platelet capacity.

17 March 2026 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
MVMiguel Vazquez-Gomez
Miguel Vazquez-Gomez
Roberto SeijasRoberto Seijas
Roberto Seijas
PAPedro Alvarez-Díaz
Pedro Alvarez-Díaz
PLPatricia Laiz
Patricia Laiz
AFAlfred Ferré-Aniorte
Alfred Ferré-Aniorte
RCRamon Cugat
Ramon Cugat

23 June 2026 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Closed access
DBDavid Barastegui
David Barastegui
PVPaula Velasco
Paula Velasco
AMAlessandro Malatesta
Alessandro Malatesta
AFAlfred Ferre-Aniorte
Alfred Ferre-Aniorte
RSRoberto Seijas
Roberto Seijas
RCRamon Cugat
Ramon Cugat